Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Arrhythmias

  Free Subscription


Articles published in Cardiovasc Res

Retrieve available abstracts of 46 articles:
HTML format



Single Articles


    August 2025
  1. HADAYA J, Boukens BJD, Janse MJ, Cha S, et al
    Right stellate ganglion stimulation modulates arrhythmogenesis in acute left lateral ventricular ischaemia.
    Cardiovasc Res. 2025;121:1385-1391.
    PubMed     Abstract available


    July 2025
  2. GIAMMARINO L, Matas L, Alerni N, Horvath A, et al
    Sex and sex hormonal regulation of the atrial inward rectifier potassium current (IK1): insights into potential pro-arrhythmic mechanisms.
    Cardiovasc Res. 2025;121:1215-1227.
    PubMed     Abstract available


    June 2025
  3. MASON FE, Liutkute A, Voigt N
    Testosterone and atrial fibrillation: does the dose make the poison?
    Cardiovasc Res. 2025 Jun 21:cvaf113. doi: 10.1093.
    PubMed    


    May 2025
  4. RUBERTO F, Foo R
    Atrial fibrillation: a measure from one circular RNA.
    Cardiovasc Res. 2025 May 19:cvaf083. doi: 10.1093.
    PubMed    


  5. GAO Y, Dong Y, Jiang N, Zhang H, et al
    Atrial remodelling and atrial fibrillation self-sustaining: the role of circulating circDGCR8.
    Cardiovasc Res. 2025 May 8:cvaf060. doi: 10.1093.
    PubMed     Abstract available


    April 2025
  6. KEEFE JA, Wang J, Song J, Ni L, et al
    Immune cells and arrhythmias.
    Cardiovasc Res. 2025;121:382-395.
    PubMed     Abstract available


  7. MUNOZ-MARTIN N, Simon-Chica A, Diaz-Diaz C, Cadenas V, et al
    Meis transcription factors regulate cardiac conduction system development and adult function.
    Cardiovasc Res. 2025;121:311-323.
    PubMed     Abstract available


  8. MIRA HERNANDEZ J, Shen EY, Ko CY, Hourani Z, et al
    Differential sex-dependent susceptibility to diastolic dysfunction and arrhythmia in cardiomyocytes from obese diabetic heart failure with preserved ejection fraction model.
    Cardiovasc Res. 2025;121:254-266.
    PubMed     Abstract available


  9. LIN S, Schwartz TH, Pitt GS
    Sudden unexpected death in epilepsy: respiratory vs. cardiac contributions.
    Cardiovasc Res. 2025;120:2385-2394.
    PubMed     Abstract available


    January 2025
  10. LIU W, Liu J, Wang G, Cheng W, et al
    Downregulation of HDAC2 attenuates ventricular arrhythmias in a mouse model of cardiac hypertrophy through upregulation of KCHIP2 expression.
    Cardiovasc Res. 2025 Jan 28:cvaf008. doi: 10.1093.
    PubMed     Abstract available


    December 2024
  11. REYAT JS, Sommerfeld LC, O'Reilly M, Roth Cardoso V, et al
    PITX2 deficiency leads to atrial mitochondrial dysfunction.
    Cardiovasc Res. 2024;120:1907-1923.
    PubMed     Abstract available


    November 2024
  12. BODI I, Mettke L, Michaelides K, Hornyik T, et al
    Beneficial normalization of cardiac repolarization by carnitine in transgenic short QT syndrome type 1 rabbit models.
    Cardiovasc Res. 2024;120:1550-1561.
    PubMed     Abstract available


    October 2024
  13. LI X, Bao Y, Zhang N, Lin C, et al
    Senescent CD8+ T cells: a novel risk factor in atrial fibrillation.
    Cardiovasc Res. 2024 Oct 9:cvae222. doi: 10.1093.
    PubMed     Abstract available


    September 2024
  14. HU W, Tu H, Wadman MC, Li YL, et al
    Renal denervation achieves its antiarrhythmic effect through attenuating macrophage activation and neuroinflammation in stellate ganglia in chronic heart failure.
    Cardiovasc Res. 2024 Sep 25:cvae196. doi: 10.1093.
    PubMed     Abstract available


  15. LI N, Cui L, Korantzopoulos P, Zhang N, et al
    Association between cumulative uric acid exposure and the risk of incident cardiac conduction block.
    Cardiovasc Res. 2024;120:1104-1106.
    PubMed    


  16. FAKIH W, Mroueh A, Gong DS, Kikuchi S, et al
    Activated factor X stimulates atrial endothelial cells and tissues to promote remodelling responses through AT1R/NADPH oxidases/SGLT1/2.
    Cardiovasc Res. 2024;120:1138-1154.
    PubMed     Abstract available


    July 2024
  17. COLEMAN JA, Doste R, Ashkir Z, Coppini R, et al
    Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.
    Cardiovasc Res. 2024;120:914-926.
    PubMed     Abstract available


    May 2024
  18. LIUTKUTE A, Prosser BL, Voigt N
    Microtubules: highway to ... arrhythmia?
    Cardiovasc Res. 2024;120:671-672.
    PubMed    


  19. ODENING KE
    Interactions between KCNQ1 and KCNH2 may modulate the long QT type 1 phenotype.
    Cardiovasc Res. 2024;120:673-674.
    PubMed    


  20. WADA Y, Wang L, Hall LD, Yang T, et al
    The electrophysiologic effects of KCNQ1 extend beyond expression of IKs: evidence from genetic and pharmacologic block.
    Cardiovasc Res. 2024;120:735-744.
    PubMed     Abstract available


  21. PAVLAKI N, Froese A, Li W, De Jong KA, et al
    Gene therapy with phosphodiesterases 2A and 4B ameliorates heart failure and arrhythmias by improving subcellular cAMP compartmentation.
    Cardiovasc Res. 2024 May 22:cvae094. doi: 10.1093.
    PubMed     Abstract available


  22. KEEFE JA, Zhao S, Wehrens XHT
    A mechanistic LNK between inflammation and atrial fibrillation?
    Cardiovasc Res. 2024 May 7:cvae083. doi: 10.1093.
    PubMed    


    April 2024
  23. MEHDIZADEH M, Naud P, Abu-Taha IH, Hiram R, et al
    The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology.
    Cardiovasc Res. 2024;120:506-518.
    PubMed     Abstract available


  24. KAHNERT K, Soattin L, Mills RW, Wilson C, et al
    Proteomics couples electrical remodelling to inflammation in a murine model of heart failure with sinus node dysfunction.
    Cardiovasc Res. 2024 Apr 25:cvae054. doi: 10.1093.
    PubMed     Abstract available


  25. FABRITZ L, Chua W, Cardoso VR, Al-Taie C, et al
    Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study.
    Cardiovasc Res. 2024 Apr 13:cvae067. doi: 10.1093.
    PubMed     Abstract available


    March 2024
  26. DE COSTER T, Teplenin AS, Feola I, Bart CI, et al
    'Trapped re-entry' as source of acute focal atrial arrhythmias.
    Cardiovasc Res. 2024;120:249-261.
    PubMed     Abstract available


  27. TONKO JB, Lambiase PD
    The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies.
    Cardiovasc Res. 2024;120:114-131.
    PubMed     Abstract available


    February 2024
  28. KIZER JR
    The elusive quest for causality in adiponectin's bimodal relationship with cardiovascular disease: Mendelian randomization meets Janus.
    Cardiovasc Res. 2024;120:3-5.
    PubMed    


  29. HARDING D, Fanti S, Marelli-Berg F
    Tumour necrosis factor-alpha in cardiac inflammation: friend or foe?
    Cardiovasc Res. 2024;120:1-2.
    PubMed    


  30. HEIJMAN J, Madreiter-Sokolowski CT
    Is ageing a modifiable risk factor for atrial fibrillation?
    Cardiovasc Res. 2024 Feb 26:cvae040. doi: 10.1093.
    PubMed    


  31. FABRITZ L, Lemoine MD
    Atrial fibrillation in the young: consider heritable conditions like short QT syndrome.
    Cardiovasc Res. 2024 Feb 22:cvae041. doi: 10.1093.
    PubMed    


  32. VELASCO JJ, Akar FG
    A new year's resolution to resolve atrial fibrillation: Resolvin D1 emerges as a powerful target against post-MI atrial remodeling.
    Cardiovasc Res. 2024 Feb 22:cvae039. doi: 10.1093.
    PubMed    


  33. MURPHY MB, Yang Z, Subati T, Farber-Eger E, et al
    LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation.
    Cardiovasc Res. 2024 Feb 20:cvae036. doi: 10.1093.
    PubMed     Abstract available


  34. ROGERS AJ, Narayan SM
    Latent drivers for atrial fibrillation and specific patterns of localized fibrosis.
    Cardiovasc Res. 2024 Feb 20:cvae032. doi: 10.1093.
    PubMed    


    January 2024
  35. NGUYEN MN, Hooper C, Stefanini M, Vrellaku B, et al
    Why is early-onset atrial fibrillation uncommon in patients with Duchenne Muscular Dystrophy? Insights from the mdx mouse.
    Cardiovasc Res. 2024 Jan 25:cvae022. doi: 10.1093.
    PubMed     Abstract available


  36. MORENO-MANUEL AI, Macias A, Cruz FM, Gutierrez LK, et al
    The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of Short QT Syndrome type 3.
    Cardiovasc Res. 2024 Jan 23:cvae019. doi: 10.1093.
    PubMed     Abstract available


  37. SHI Q, Malik H, Crawford RM, Streeter J, et al
    Cardiac MAO-A inhibition protects against catecholamine-induced ventricular arrhythmias via enhanced diastolic calcium control.
    Cardiovasc Res. 2024 Jan 10:cvae012. doi: 10.1093.
    PubMed     Abstract available


    December 2023
  38. DOREY TW, McRae MD, Belke DD, Rose RA, et al
    PDE4D mediates impaired beta-adrenergic receptor signalling in the sinoatrial node in mice with hypertensive heart disease.
    Cardiovasc Res. 2023;119:2697-2711.
    PubMed     Abstract available


  39. OLCUM M, Fan S, Rouhi L, Cheedipudi S, et al
    Genetic inactivation of beta-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy.
    Cardiovasc Res. 2023;119:2712-2728.
    PubMed     Abstract available


  40. HIRAM R, Xiong F, Naud P, Xiao J, et al
    An inflammation resolution-promoting intervention prevents atrial fibrillation due to left-ventricular dysfunction.
    Cardiovasc Res. 2023 Dec 13:cvad175. doi: 10.1093.
    PubMed     Abstract available


    October 2023
  41. NIELSEN MB, Colak Y, Benn M, Mason A, et al
    Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large scale observational and Mendelian randomization evidence.
    Cardiovasc Res. 2023 Oct 28:cvad162. doi: 10.1093.
    PubMed     Abstract available


  42. NI H, Morotti S, Zhang X, Dobrev D, et al
    Integrative human atrial modelling unravels interactive protein kinase A and Ca2+/calmodulin-dependent protein kinase II signalling as key determinants of atrial arrhythmogenesis.
    Cardiovasc Res. 2023;119:2294-2311.
    PubMed     Abstract available


  43. JONES CA, Wallace MJ, Bandaru P, Woodbury ED, et al
    E-cigarettes and arrhythmogenesis: a comprehensive review of pre-clinical studies and their clinical implications.
    Cardiovasc Res. 2023;119:2157-2164.
    PubMed     Abstract available


    September 2023
  44. VENKATESHAPPA R, Hunter DV, Muralidharan P, Nagalingam RS, et al
    Targeted activation of hERG channels rescues electrical instability induced by the hERG R56Q+/- Long QT Syndrome variant.
    Cardiovasc Res. 2023 Sep 21:cvad155. doi: 10.1093.
    PubMed     Abstract available


  45. LAKIN R, Polidovitch N, Yang S, Parikh M, et al
    Cardiomyocyte and endothelial cells play distinct roles in the tumor necrosis factor (TNF)-dependent atrial responses and increased atrial fibrillation vulnerability induced by endurance exercise training in mice.
    Cardiovasc Res. 2023 Sep 15:cvad144. doi: 10.1093.
    PubMed     Abstract available


  46. SEIBERTZ F, Rubio T, Springer R, Popp F, et al
    Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.
    Cardiovasc Res. 2023 Sep 7:cvad143. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.